Healius Limited
ASX: HLS
“Healius Poised for a Leaner Future with Profitable Path Ahead”
(Source: TradingView) 3-Month Performance Profile of HLS on a DTF compared to ASX 200 (XJO)
Healius reported a 5.7% group revenue increase to $1.34 billion, with underlying EBITDA at $239.3 million and EBIT at $17.1 million, broadly meeting expectations. A one-off $375.2 million gain from the Lumus Imaging sa
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
